EFDID: 311956EFD: View Filing

Issuer: INNOVATE BIOPHARMACEUTICALS, INC. (0001551986) - D

Accession: 0001551986-19-000047 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001551986
  • Entity Name:
    INNOVATE BIOPHARMACEUTICALS, INC.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    8480 HONEYCUTT ROAD
    SUITE 120
    RALEIGH, NC 27615
  • Persons:
    Related Persons 6
    Sandeep Laumas
    Executive Officer, Director
    Jay Madan
    Executive Officer, Director
    Anthony Maida
    Director
    Lorin Johnson
    Director
    Saira Ramasastry
    Director
    Roy Proujansky
    Director
EDGAR: Offering Information
  • Accession Date:
    05/14/2019
  • First Sale Date:
    05/01/2019
  • Offering Amount:
    $8,744,501
  • Amount Sold:
    $8,744,501
  • Exemptions:
    Rule 506
  • Security Type(s):
  • Sales Clarification:
    Warrants to purchase up to 4,318,272 shares common, exercise price $2.13, issued to investors in registered equity offering, warrants to purchase up to 215,914 shares of common, exercise price $2.53125, issued to H.C. Wainwright, and underlying shares.
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:NJ
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
H.C. Wainwright & Co., LLC 375 H.C. Wainwright & Co., LLC 375 FL, NJ, NY
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
INNOVATE BIOPHARMACEUTICALS, INC.Jay MadanJay MadanChief Business Officer2019-05-14